Immunotherapy, a rapidly evolving field in medicine, harnesses the body's immune system to combat diseases, particularly cancer. This article provides a comprehensive guide for physicians to understand the fundamental principles and clinical applications of immunotherapy.
Immunotherapy is a biological therapy that boosts or manipulates the immune system to fight disease. It includes treatments such as monoclonal antibodies, cancer vaccines, and immune checkpoint inhibitors. These therapies can either stimulate the immune system to work harder or smarter to attack cancer cells or provide the immune system with components, such as man-made immune system proteins.
Immunotherapy has emerged as a promising approach in cancer treatment. It has shown effectiveness in treating several types of cancer, including lung, melanoma, and lymphoma. Notably, immune checkpoint inhibitors have revolutionized the treatment of these cancers by blocking the signals that prevent the immune system from attacking cancer cells. However, the response to immunotherapy varies among patients, and not all types of cancer respond to these treatments.
Despite its potential, immunotherapy faces several challenges. These include predicting who will respond to treatment, managing immune-related adverse events, and understanding resistance mechanisms. Additionally, the high cost of immunotherapy treatments is a significant barrier to their widespread use.
Research is ongoing to overcome these challenges and expand the utility of immunotherapy. Efforts are underway to identify biomarkers that predict response, develop combination therapies, and understand the tumor microenvironment. Furthermore, novel immunotherapies, such as CAR-T cell therapy, are showing promise in early-phase clinical trials.
In conclusion, immunotherapy is a transformative approach in medicine, particularly in oncology. Physicians must stay updated on its principles, clinical applications, and challenges to provide optimal care for their patients.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation